Defibrillators

The devices will be used in case of cardiac arrest.

The OEM, which received a Homeland Security grant, strives to have an AED placed in every Metro-owned building.

The Nashville Fire Department, a member of the Nashville Public Access Defibrillation program, will train about 80 teachers and coaches from Metro Schools to be CPR/AED instructors this summer.

As part of a grant the Nashville Fire Department is currently seeking, the fire department will set up a system to train between 8,000-10,000 students annually in CPR and AED use.

"This is a collaboration between two city departments to establish a sustainable CPR/AED in schools program for Nashville," Halford said in a news release.

"We're very excited to see more people in Nashville will be CPR and AED trained because of this program." Local News Headlines Metro Schools To Receive Debrillators Accused Rapist, Robber Hangs Self In Cell Metro Officer Arrested For Domestic Assault State Is Winding Down Its Case In Ford Trial ASCAP Honors Christian Artists All content © Copyright 2000 - 2007 WorldNow and WTVF.

All Rights Reserved.For more information on this site, please read our Privacy Policy and Terms of Service.

...

Worldwide sales of the drug-eluting coronary stent systems for the first quarter of 2007 were $468 million as compared to $633 million for the first quarter of 2006, and $506 million for the fourth quarter of 2006.

The Guidant deal also included an agreement with Abbott Laboratories (ABT, 57.00, -0.21) to divest Guidant's vascular intervention and endovascular businesses.

In the latest quarter, Boston Scientific incurred SG&A costs of $735 million compared to only $470 million last year, partially due to acquisition-related costs.

In December, BSX and Johnson & Johnson (JNJ, 64.66 -0.09) told the U.S.

Food and Drug Administration that their products are safe for a broad range of patients, despite the fact that research has shown that stents may cause blood clots months after implantation.

An FDA panel soon after said the benefits of drug-coated stents appeared to outweigh their risks as long as they are used as intended.

The company said second quarter earnings per share are expected to be $0.15 to $0.20, excluding items, versus consensus of $0.22.

Second quarter revenues are anticipated to fall in a range of $2.0 billion to $2.1 billion (consensus $2.12 billion).

-Christine Marie Nielsen, ...